Cargando…
Ex Vivo Integration of Human Stem Retinal Ganglion Cells into the Mouse Retina
Cell replacement therapies may be key in achieving functional recovery in neurodegenerative optic neuropathies diseases such as glaucoma. One strategy that holds promise in this regard is the use of human embryonic stem cell and induced pluripotent stem-derived retinal ganglion cells (hRGCs). Previo...
Autores principales: | Croteau, Louis-Philippe, Risner, Michael L., Wareham, Lauren K., McGrady, Nolan R., Chamling, Xitiz, Zack, Donald J., Calkins, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600680/ https://www.ncbi.nlm.nih.gov/pubmed/36291110 http://dx.doi.org/10.3390/cells11203241 |
Ejemplares similares
-
Intrinsic Morphologic and Physiologic Development of Human Derived Retinal Ganglion Cells In Vitro
por: Risner, Michael L., et al.
Publicado: (2021) -
Microfluidic Platforms Promote Polarization of Human-Derived Retinal Ganglion Cells That Model Axonopathy
por: Boal, Andrew M., et al.
Publicado: (2023) -
Neutral sphingomyelinase inhibition promotes local and network degeneration in vitro and in vivo
por: Risner, Michael L., et al.
Publicado: (2023) -
Bax Contributes to Retinal Ganglion Cell Dendritic Degeneration During Glaucoma
por: Risner, Michael L., et al.
Publicado: (2022) -
Sensitivity to extracellular potassium underlies type-intrinsic differences in retinal ganglion cell excitability
por: Boal, Andrew M., et al.
Publicado: (2022)